RILEXINE H.L.
RILEXINE H.L.
Authorised
- Cephalexin benzathine
Product identification
Medicine name:
RILEXINE H.L.
Active substance:
- Cephalexin benzathine
Target species:
-
Cattle (cow)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Cephalexin benzathine500.00/milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
- Cattle (cow)
-
Meat and offal4day
-
Milk43day42,5 jours après le traitement, si la période de tarissement est inférieure à 42 jours.
-
Milk12hour12 heures après le vêlage si la période de tarissement est supérieure ou égale à 42 jours.
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51DB01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- Virbac
Responsible authority:
- National Veterinary Medicines Agency
Authorisation number:
- FR/V/8888140 3/1989
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
How useful was this page?:
